Cannabis Report
Home > Boards > US OTC > Biotechs >

Oncolix Inc. (ONCX)

ONCX RSS Feed
Add ONCX Price Alert      Hide Sticky   Hide Intro
Moderator: reaper247, BeeDoubleU, Rat Fink, namtae, AltJactUp, steadyhand
Search This Board: 
Last Post: 6/15/2018 11:29:13 PM - Followers: 163 - Board type: Free - Posts Today: 0



A pharmaceutical company in Harris County, Texas.
OTCQB: ONCX

14405 Walters Rd, Houston, TX 77014
(281) 402-3168
Contact Us
\

Oncolix, Inc. (Oncolix) is a clinical-stage biotechnology company

We are developing Prolanta™, a targeted therapeutic protein for the treatment of ovarian, breast and other cancers. The Company has a US FDA-cleared IND to commence human testing of Prolanta™ in our first indication, the treatment of ovarian cancer.  This clinical trial began in 2016. Preliminary data from the first dosing group (the low dose) of this trial suggest Prolanta is safe with some evidence of efficacy in a patient population that is difficult to treat. Prolanta™ is a prolactin receptor antagonist that has demonstrated significant efficacy in xenograft models through a unique mechanism of action, autophagy (see Our Science). In addition to ovarian cancer, there is strong preclinical evidence Prolanta™ will be effective in breast, prostate and other cancers.

The FDA has also approved the designation of Prolanta™ as an Orphan Drug for the treatment of ovarian cancer, which may allow reduced filing fees, federal tax credits and marketing exclusivity by the FDA.

Proudly partnered with Greenville Health System

Oncolix, Inc. (Oncolix) is a bio-pharmaceutical company originally established at the Greenville Health System through the innovative efforts of the Oncology Research Institute in conjunction with the GHS Cancer Center drug discovery program. Oncolix, now based in Houston, Texas, is currently focusing on phase one clinical trials of Prolanta™ - a targeted therapeutic protein for the treatment of breast and ovarian cancer. Prolanta™ was pioneered within the Oncology Research Institute (now known as the Clemson Biomedical Institute) at GHS in Greenville, SC.


Proudly partnered with MD Anderson Cancer Treatment Center


MD Anderson has been ranked the No. 1 hospital for cancer care in the nation by U.S. News & World Report’s “Best Hospitals” survey.

 

Oncolix patents

Oncolix has 30 patents in their patent portfolio, including 8 U.S patents.

\

 
ONCX Security Details
Share Structure
  Market Value1 $5,801,028 a/o Dec 01, 2017
Authorized Shares 950,000,000 a/o Dec 01, 2017
Outstanding Shares 103,877,936 a/o Dec 01, 2017
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float 33,311,633 a/o Apr 06, 2017
  Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record 101 a/o Apr 06, 2017

As per OTC markets. Updates are pending


Who is Oncolix, Inc.?

https://oncolixbio.com

April 2017 Company Presentation:
https://nebula.wsimg.com/8b544fcbb6f5bf5fb52c1c7e5a69eb81?AccessKeyId=D34B304F5C474C27E878&disposition=0&alloworigin=1

 

Early funding for Prolactin research was granted from the Susan G. Komen foundation and the U.S government.
More recent funding came from accredited investment including TEXAS TREASURY SAFEKEEPING TRUST CO and the Ernest Mario Family Trust.
Ernest Mario is an American pharmaceutical industry executive and the recipient of the 2007 Remington Honor Medal awarded by the American Pharmacists Association.

 

\

Ernest Mario is the former CEO of GlaxoSmithKilne NYSE: GSK.

He is also Rutgers University alumni who has had the Rutgers School of Pharmacy named after him.


Potential revenue moving forward.

 

 

The Oncolix Team

Management

\

\

Board Members

\

\

\

Prolanta Inventor

\

Company Advisors

\

\



 




 


This space reserved for updates.

 



https://www.otcm
arkets.com/edgar/GetFilingHtml?FilingID=12149068

Cannabis Report
ONCX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AEPP News: Statement of Ownership (sc 13g) 02/16/2018 10:50:47 AM
AEPP News: Amended Statement of Beneficial Ownership (3/a) 02/15/2018 11:24:44 AM
AEPP News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 02/09/2018 06:13:48 AM
AEPP News: Notice of Effectiveness (effect) 02/09/2018 06:01:55 AM
AEPP News: Securities Registration Statement (s-1/a) 02/05/2018 11:57:32 AM
PlusOneCoin Top Posts
#17866   LOL, laraz, this is fun. Lets take a look. reaper247 06/14/18 02:32:43 AM
PostSubject
#17864  Sticky Note 6/5/18 PR "ONCX" COMPLETES FINANCING &_RESTRUCTURES_EXISTING_DEBT![/i Rat Fink 06/12/18 10:14:06 PM
#17849  Sticky Note Oncolix OTC: ONCX is a pharmaceutical company that reaper247 06/07/18 12:10:14 AM
#17139  Sticky Note Cutting through the ONCX clutter and nonsense. reaper247 03/22/18 01:12:28 AM
#17878   VERY NICE "ONCX" 8.33% GAIN TODAY!!! CONTINUES GOING_UP!!! Rat Fink 06/15/18 11:29:12 PM
#17876   So are they possibly just kicking the can mathew633 06/15/18 06:47:21 PM
#17875   If the note holders didnt renegotiate, they'd be namtae 06/15/18 06:43:27 PM
#17874   But if it's poor results so far why mathew633 06/15/18 06:37:58 PM
#17873   Still no word on the clinicals namtae 06/15/18 06:33:23 PM
#17872   Strange price action today. Did someone get AltJactUp 06/15/18 03:08:41 PM
#17871   6/5/18 PR "ONCX" COMPLETES FINANCING &_RESTRUCTURES_EXISTING_DEBT![ Rat Fink 06/15/18 09:47:41 AM
#17870   OUTSTANDING 4/24/17 CEO MICHAEL REDMAN_INTERVIEW_BEFORE_ONCOLIX_REVERSED-M Rat Fink 06/15/18 12:08:42 AM
#17869   OUTSTANDING PRESENTATION ON ONCOLIXs_PROLANTA_EFFECTS_ON_WOMENs_CANCERS!!! Rat Fink 06/14/18 11:00:24 PM
#17868   NICE "ONCX" 10% GAIN TODAY!!! ;-) Rat Fink 06/14/18 10:04:51 PM
#17866   LOL, laraz, this is fun. Lets take a look. reaper247 06/14/18 02:32:43 AM
#17865   Its been 865 days since Prolanta has been laraz5 06/13/18 05:00:52 PM
#17864   6/5/18 PR "ONCX" COMPLETES FINANCING &_RESTRUCTURES_EXISTING_DEBT![/i Rat Fink 06/12/18 10:14:06 PM
#17863   BIOPHARMA ONCX/ONCOLIX HAS "8" U.S. PATENTS_&_MANY_FOREIGN_PATENTS! Rat Fink 06/11/18 10:26:02 PM
#17862   Pfffttt…1vamn, enough said? What? reaper247 06/10/18 01:40:02 AM
#17861   OUTSTANDING 4/24/17 CEO MICHAEL REDMAN_INTERVIEW_BEFORE_ONCOLIX_REVERSED-M Rat Fink 06/09/18 07:03:35 PM
#17860   *****Here's the most important fact !!! ONCX junk 1vman 06/09/18 06:53:25 PM
#17859   REAPER, GREAT POST 17856!!! GREAT "ONCX"_FACTS!!!_GO_"ONCX"!!! Rat Fink 06/09/18 01:01:25 PM
#17858   GREAT CEO INTERVIEW ON PROLANTA_DEVELOPMENT_FOR_WOMEN'S_CANCERS_(12/6/17) Rat Fink 06/09/18 11:53:41 AM
#17857   *****Far from outstanding !!! the market obviously disagrees 1vman 06/09/18 10:39:37 AM
#17856   LOL, 1vman…what? Seriously? reaper247 06/09/18 02:23:54 AM
#17855   OUTSTANDING NEW PRESENTATION OUT ON ONCX/ONCOLIX's_PROLANTA_EFFECTS_ON_WOMEN'S Rat Fink 06/09/18 12:42:06 AM
#17853   *****Volume and interest shrivelling up here ! Lots 1vman 06/08/18 09:07:40 PM
#17852   BIOPHARMA ONCX/ONCOLIX HAS "8" U.S. PATENTS_&_MANY_FOREIGN_PATENTS! Rat Fink 06/08/18 04:59:41 PM
#17851   OUTSTANDING 4/24/17 CEO MICHAEL REDMAN_INTERVIEW_BEFORE_ONCOLIX_REVERSED-M Rat Fink 06/08/18 02:49:20 PM
#17850   6/5/18 PR, "ONCX" COMPLETES $1.2 MILLION FINANCING_&_RESTRUCTURES_EXISTING Rat Fink 06/08/18 12:07:38 PM
#17849   Oncolix OTC: ONCX is a pharmaceutical company that reaper247 06/07/18 12:10:14 AM
#17847   Agree. Big hurdle now is just waiting CatfishHunter 06/06/18 04:05:04 PM
#17846   I wonder if the extra million is enough Bored Lawyer 06/06/18 03:55:31 PM
#17845   Its been 858 days since Prolanta has been laraz5 06/06/18 12:38:35 PM
#17844   Volume coming in. #LOADING steadyhand 06/06/18 12:03:49 PM
#17843   8K out today BLight1911 06/06/18 11:48:31 AM
#17841   6/5/18 PR, "ONCX" COMPLETES $1.2 MILLION FINANCING_&_RESTRUCTURES_EXISTING_DEBT! Rat Fink 06/06/18 10:38:34 AM
#17840   GREAT NEWS! LETS GO ONCX! steadyhand 06/06/18 09:53:51 AM
#17839   Generally speaking, a better deal than I anticipated namtae 06/06/18 07:43:35 AM
#17838   Thank you for the clarification. Exciting times ahead! maro1 06/06/18 07:00:13 AM
#17837   Lets shatter a trading myth and expand on reaper247 06/06/18 01:19:28 AM
#17836   I am definitely no expert either, but this reaper247 06/06/18 12:49:23 AM
#17834   Outstanding news for ONCX. reaper247 06/06/18 12:17:21 AM
#17833   OUTSTANDING PRESENTATION ON ONCOLIXs_PROLANTA_EFFECTS_ON_WOMENs_CANCERS!!! Rat Fink 06/05/18 11:20:07 PM
#17832   You are correct soak 06/05/18 09:16:43 PM
#17831   Results of the trials will prove Oncolix has DayDreeming 06/05/18 09:10:38 PM
#17830   I definitely understand that. My optimism is soak 06/05/18 09:01:08 PM
#17829   Don't kid yourself, the majority of bio-tech companies DayDreeming 06/05/18 08:59:02 PM
#17828   I do not believe money would be loaned soak 06/05/18 08:50:15 PM
#17827   What a joke ONCX borrowing a million dollars laraz5 06/05/18 08:38:28 PM
#17826   This gives the co. pba1969 06/05/18 07:57:37 PM
#17825   I'm definitely no expert, but it doesn't look maro1 06/05/18 06:50:57 PM
#17824   https://www.accesswire.com/501831/Oncolix-Inc-Completes-12-Million-Financing-and AltJactUp 06/05/18 06:29:38 PM
#17823   Oncolix will need to disclose something this week, namtae 06/05/18 01:41:34 PM
PostSubject